Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal

References

• Report of the US Department of Health and Human Services. The 2011 national blood collection and utilization survey report. US Department of Health and Human Services, Office of the Assistant Secretary for Health, Washington DC, 2011
   Google Scholar
• Fresh frozen plasma usage in six New Zealand Hospitals Charlewood R. New Zealand Blood Service, New Zealand; 2008
   Google Scholar
• HCUPnet Nationwide Inpatient Sample Agency for Healthcare Research and Quality. Agency for Healthcare Research and Quality, Rockville, MD; 2009
   Google Scholar
• Hickey M, Gatien M, Taljaard M, et al. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department. Circulation 2013;128(4):360-4
   PubMed Web of Science ®Google Scholar
• PHB Bolton-Maggs, Poles D, Watt A, Thomas D. On behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2013 Annual SHOT Report; 2014
   Google Scholar
• Sarode R, Milling TJJr, Refaai MA, et al. Efficacy and safety of a 4-factor prothrombin complex concentrates on vitamin L antagonists presenting with major bleeding: a randomized, plasma controlled, phase IIIb study. Circulation 2013;128(11):1234-43
   PubMed Web of Science ®Google Scholar
• Popovsky MA, Robillard P, Schipperus M, et al. ISBT/IHN Working Party on Haemovigilance. Proposed standard definitions for surveillance of non-infectious adverse transfusion reactions. 2011. Available from: www.ihn-org.com/wp-content/uploads/2011/06/ISBT-definitions-for-non-infectious-transfusion-reactions.pdf
   Google Scholar
• Tazarourte K, Riou B, Tremey B, et al. EPAHK study group. Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study). Crit Care 2014;18(2):R81
   PubMed Web of Science ®Google Scholar
• Shih AW, Kolesar E, Ning S, et al. Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study. Vox Sang 2015;108(3):274-80
   PubMed Web of Science ®Google Scholar
• Görlinger K, Fries D, Dirkmann D, et al. Reduction of Fresh Frozen Plasma Requirements by Perioperative Point-of-Care Coagulation Management with Early Calculated Goal-Directed Therapy. Transfus Med Hemother 2012;39(2):104-13
   PubMed Web of Science ®Google Scholar
• Mallaiah S, Barclay P, Harrod I, et al. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia 2015;70(2):166-75
   PubMed Web of Science ®Google Scholar
• Graph pad software. 2015. Available from: http://graphpad.com/quickcalcs/contingency2/
   Google Scholar
• Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012;117(3):531-47
   PubMed Web of Science ®Google Scholar
• Görlinger K, Dirkmann D, Hanke AA, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 2011;115(6):1179-91
   PubMed Web of Science ®Google Scholar
• Cooper LM, Linde-Zwirble WT. Medicare intensive care unit use: analysis of incidence, cost, and payment. Crit Care Med 2004;32(11):2247-53
   PubMed Web of Science ®Google Scholar
• Payment Allowance Limits for Medicare Part B Drugs Centers for Medicare & Medicaid Services. US.Department of Health & Human Services, Baltimore, MD; 2011
   Google Scholar
• Compound Interest Formula DePaul University Quantitative Reasoning Center. DePaul University Information Services, Chicago, IL; 2011
   Google Scholar
• Tan SS, Bakker J, Hoogendoorn ME, et al. Direct cost analysis of intensive care unit stay in four European countries: applying a standardized costing methodology. Value Health 2012;15(1):81-6
   PubMed Web of Science ®Google Scholar
• Arneson TJ, Liu J, Qiu Y, et al. Hospital treatment for fluid overload in the Medicare hemodialysis population. Clin J Am Soc Nephrol 2010;5(6):1054-63
   PubMed Web of Science ®Google Scholar
• Ozgonenel B, O’Malley B, Krishen P, et al. Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital. Am J Hematol 2007;82(12):1091-4
   PubMed Web of Science ®Google Scholar
• Clifford L, Jia Q, Subramanian A, et al. Characterizing the epidemiology of postoperative transfusion-related acute lung injury. Anesthesiology 2015;122(1):12-20
   PubMed Web of Science ®Google Scholar
• Triulzi DJ. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg 2009;108(3):770-6
   PubMed Web of Science ®Google Scholar
• Lee SB, Manno EM, Layton KF, Wijdicks EF. Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP. Neurology 2006;67(7):1272-4
   PubMed Web of Science ®Google Scholar
• Guest JF, Watson HG, Limaye S. Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United kingdom. Clin Ther 2010;32(14):2478-93
   PubMed Web of Science ®Google Scholar
• Aiyagari V, Testai FD. Correction of coagulopathy in warfarin associated cerebral hemorrhage. Curr Opin Crit Care 2009;15(2):87-92
   PubMed Web of Science ®Google Scholar
• Magee G, Peters C, Zbrozek A. Analysis of inpatient use of fresh frozen plasma and other therapies and associated outcomes in patients with major bleeds from vitamin K antagonism. Clin Ther 2013;35(9):1432-43
   PubMed Web of Science ®Google Scholar